Evidence map›Paper›PMID 39335848›Full record

ArticleFoods (Basel, Switzerland)2024

High-Yield Expressed Human Ferritin Heavy-Chain Nanoparticles in

Xinyi Lu, Liping Liu, Haibo Zhang, Haifang Lu, Tian Tian, Bing Du, Pan Li, Yao Yu, Jungang Zhou, Hong Lu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Foods (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xinyi LuState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.
Liping LiuState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.
Haibo ZhangNorth America Nutrition Research and Development Society, Guangzhou Aoungo Biotech Co., Ltd., Guangzhou 510310, China.
Haifang LuState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.
Tian TianState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.
Bing DuCollege of Food Science, South China Agricultural University, Guangzhou 510642, China.
Pan LiCollege of Food Science, South China Agricultural University, Guangzhou 510642, China.
Yao YuState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0003-0090-8193
Jungang ZhouState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0001-9618-1683
Hong LuState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.

Funding

Science and Technology Research Program of Shanghai 23HC1400600Shanghai Municipal Education Commission 2021-03-52the National Key Research and Development Program of China 2021YFA0910601the Science and Technology Research Program of Shanghai 2023ZX01
6 · The paper itself

Abstract

The use of Generally Recognized as Safe (GRAS)-grade microbial cell factories to produce recombinant protein-based nutritional products is a promising trend in developing food and health supplements. In this study, GRAS-grade

Indexed as

functional foodsKluyveromyces marxianusnanoparticlerecombinant ferritin

Identifiers

PMID39335848
PMCPMC11431416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.